Patent directory · USPTO A61K / A61P
Patents matching “Northwestern University”
565 pharma patents match "Northwestern University" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 565 pharmaceutical patents matching "Northwestern University" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 11453640
Small molecules for disrupting the super elongation complex and inhibiting transcription elongation for cancer therapy
granted -
US 11439632
Use of neuronal nitric oxide synthase inhibitors for immunotherapy in melanoma patients
granted -
US 11439635
B cell lymphoma 6 protein (BCL6) as a target for treating diabetes mellitus and non-alcoholic fatty liver disease
granted -
US 11433131
Adoptive cell therapy using spherical nucleic acids (SNAs)
granted -
US 11413337
Peptide conjugated particles for the treatment of inflammation
granted -
US 11401387
Photocontrolled dynamic covalent linkers for polymer networks
granted -
US 11389517
Peptide conjugated particles
granted -
US 11369622
Methods and compounds to inhibit enveloped virus release
granted -
US 11371008
Systems for producing cellular immunotherapeutics and methods of use thereof
granted -
US 11364304
Crosslinked micellar spherical nucleic acids
granted -
US 11344569
Treatment of sleep-wake disorders and neurodegenerative disease comprising modified resistant maltodextrin
granted -
US 11311485
Self-assembled particles for targeted delivery of immunomodulators to treat autoimmunity and cancer
granted -
US 11304988
Inhibiting tumor cell migration by inhibition of kinesin light chain 1, variant 1 (KLC1C)
granted -
US 11299496
Ligands for alpha-7 nicotinic acetylcholine receptors and methods of treating neurological and inflammatory conditions
granted -
US 11298430
Magnetic nanocomposite compositions
granted -
US 11285106
Synthetic nanostructures including nucleic acids and/or other entities
granted -
US 11246871
Targeting adenosine A2A receptors for the treatment of levodopa-induced dyskinesias
granted -
US 11241478
Adenovirus-associated viral vectors for expressing variants of tetratricopeptide repeat (TPR)-containing Rab8b interacting (TRIP8b) protein in neurons and uses thereof for treating major depressive disorder (MDD)
granted -
US 11225483
Substituted fused pyrrolo-diazepinones and uses thereof
granted -
US 11219608
Triple combination formulation for treatment of chronic pain
granted -
US 11213593
Sequence-specific cellular uptake of spherical nucleic acid nanoparticle conjugates
granted -
US 11207283
Inactivators of toxoplasma gondii ornithine aminotransferase for treating toxoplasmosis and malaria
granted -
US 11207423
Nanocarriers having surface conjugated peptides and uses thereof for sustained local release of drugs
granted -
US 11202823
Multi-subunit vaccines to elicit both MHC- and CD1-restricted T cell responses
granted